<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="178859">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00766558</url>
  </required_header>
  <id_info>
    <org_study_id>28860</org_study_id>
    <nct_id>NCT00766558</nct_id>
  </id_info>
  <brief_title>The Effects of Written Emotional Disclosure on Eating Disorder Pathology in a Clinical Eating Disordered Population</brief_title>
  <official_title>Study of the Efficacy of Written Emotional Disclosure on Eating Disorder Pathology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Penn State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Penn State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A technique that has been found to be effective at relieving the physical and psychological
      symptoms associated with inhibiting emotions and emotional thoughts is written emotional
      disclosure. The goal of this study is to evaluate the effectiveness of written emotional
      disclosure on the remediation of eating disorder behaviour, cognitions, and management of
      emotions.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2008</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Testing and behavioral changes</measure>
    <time_frame>6-weeks</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Anorexia Nervosa</condition>
  <condition>Bulimia Nervosa</condition>
  <condition>Eating Disorder</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Written disclosure</arm_group_label>
    <description>Participant is assigned a potential stress-producing topic for written disclosure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Participant assigned a non-stressful writing condition.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in the Penn State Hershey Adolescentand Adult Eating Disorders Partial
        Hospitalization Program
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Willing to sign consent form

        Exclusion Criteria:

          -  Unwilling to sign consent form
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Richard L Levine, MD</last_name>
    <phone>7175318006</phone>
    <email>rlevine@psu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Martha P Levine, MD</last_name>
    <phone>7175317232</phone>
    <email>mlevine1@hmc.psu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Penn State College of Medicine</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Richard L Levine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <lastchanged_date>October 3, 2008</lastchanged_date>
  <firstreceived_date>October 3, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Penn State College of Medicine IRBs A, B, C and D</name_title>
    <organization>Kevin Gleeson, MD</organization>
  </responsible_party>
  <keyword>anorexia</keyword>
  <keyword>bulimia</keyword>
  <keyword>eating disorder not otherwise specified</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
    <mesh_term>Feeding and Eating Disorders</mesh_term>
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Bulimia</mesh_term>
    <mesh_term>Bulimia Nervosa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
